GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Total Stockholders Equity

Genflow Biosciences (STU:WQ5) Total Stockholders Equity : €1.01 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Total Stockholders Equity?

Genflow Biosciences's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €1.01 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Genflow Biosciences's Book Value per Share for the quarter that ended in Jun. 2024 was €0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Genflow Biosciences's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.00.

Genflow Biosciences Total Stockholders Equity Historical Data

The historical data trend for Genflow Biosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Total Stockholders Equity Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Total Stockholders Equity
0.07 2.72 0.84

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial 3.34 2.72 2.00 0.84 1.01

Genflow Biosciences  (STU:WQ5) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Genflow Biosciences's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.014-0)/349.707
=0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Genflow Biosciences's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1.014
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Total Stockholders Equity
Comparable Companies
AQSE:INC LSE:EVG LSE:APTA LSE:FAB LSE:RENE LSE:IXI LSE:CIZ LSE:OCTP LSE:IMM LSE:NFX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GENFF:USA GENF:UK
Address
6 Heddon Street, London, GBR, W1B 4BT
Website
https://www.genflowbio.com
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines